(G.N.S) Dt. 27
New Delhi
The Prime Minister’s Office (PMO) said, “PM @narendramodi will embark on a 3 city visit to personally review the vaccine development & manufacturing process. He will visit the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad & Serum Institute of India in Pune,” the PMO tweeted.
Nearly 70 per cent of Indians aged 10 and above were exposed to the SARS-CoV-2, according to ICMR’s second national serosurvey. This amounted for an estimated 74.3 million infections by the month of August, it noted. An overall seroprevalence of below 10 per cent indicated that a large proportion of Indians are still susceptible to the virus.
Amid AstraZeneca’s acknowledgement of a key error in dosage received by some study participants, the Serum Institute of India said that even at the lowest efficacy of around 70 per cent, the AstraZeneca-Oxford vaccine candidate is viable against the virus. This comes as Prime Minister Narendra Modi is set to visit the Pune-based Serum Institute of India on Saturday to review the mechanism of COVID-19 vaccine production and its distribution.
